Ignore the bashers and focus on the turnaround coming Patents
Another major factor to look at in medical marijuana stocks is their patents. If a company has a proprietary idea or intellectual property, they can roll it out around the world without worrying much about competition.
Emblem Corp. (EMC.V) (OTC: EMMBF) is a great example of this.
Emblem is primarily a medical marijuana company. It was founded by John H. Stewart, the former President and CEO of Purdue Pharma – one of the largest privately held pharmaceutical companies in the world. It’s the maker of OxyContin, which generated $3 billion in revenues just a few years ago.
The unique angle here is that they have put a patent application in for a time-release cannabinoid (CBD) pill that would allow patients to take their medicine like it should be taken.
This company could not only have a huge run up based on that patent, but it also stands a chance at being an easy acquisition target for either a large pharmaceutical company, or even a larger marijuana company like Canopy or Aurora.
Speaking of Aurora, they have just aquired CanniMed Therapeutics Inc for C$1.1 billion. CanniMed has patents, they have relationships with different universities, research and clinical trials, and export relations with other countries.
That is enough to make me take a good hard look at a medical marijuana company.
Emblem Corp. (EMC.V)(OTC: EMMBF) is a buy.